Meta downgraded, Qualcomm upgraded: Wall Street's top analyst calls

1 hour ago 1

The Fly

Thu, April 30, 2026 astatine 8:36 AM CDT 3 min read

The astir talked astir and marketplace moving probe calls astir Wall Street are present successful 1 place. Here are today's probe calls that investors request to know, arsenic compiled by The Fly.

Top 5 Upgrades:

Summit Insights upgraded Qualcomm (QCOM) to Buy from Hold station the Q1 report. The steadfast believes the negatives are priced into the shares arsenic the institution pivots towards AI.
JPMorgan upgraded Teradyne (TER) to Overweight from Neutral with an unchanged terms people of $400. The steadfast cites valuation for the upgrade pursuing the 20% post-earnings selloff.
BofA upgraded AbbVie (ABBV) to Buy from Neutral with a terms people of $234, up from $226. The steadfast believes concerns astir competitory erosion to the cardinal immunology conception are "overdone" arsenic it argues that guardant indicators for Skyrizi stay beardown and caller competitors look "category expanding."
Raymond James treble upgraded Equinix (EQIX) to Strong Buy from Market Perform with a $1,250 terms people pursuing the Q1 report. The steadfast believes Equinix is "firmly backmost successful the operator seat" aft past year's adjustments and is benefiting from AI-based demand.
Deutsche Bank upgraded SiteOne Landscape (SITE) to Buy from Hold with an unchanged terms people of $160. The steadfast views the selloff successful the shares station the Q1 study arsenic "overdone."

Top 5 Downgrades:

JPMorgan downgraded Meta Platforms (META) to Neutral from Overweight with a terms people of $725, down from $825, pursuing the Q1 report. JPMorgan is "encouraged" by Meta's 33% year-over-year gross maturation successful Q1, but says the company's accrued infrastructure spending and deficiency of visibility into its AI merchandise pipeline warrant a downgrade.
B. Riley downgraded Etsy (ETSY) to Neutral from Buy with a terms people of $75, up from $70. The steadfast sees a balanced risk/reward pursuing the post-earnings rally.
Goldman Sachs downgraded Wingstop (WING) to Neutral from Buy with a terms people of $190, down from $290, pursuing the Q1 report. The steadfast says the marque is facing "more severe" macroeconomic and competitory headwinds than expected.
Goldman Sachs downgraded GE HealthCare (GEHC) to Neutral from Buy with a terms people of $65, down from $81, pursuing the Q1 report. Goldman believes GE Healthcare's macro vulnerability volition overshadow the improving parts of its business, similar pipeline improvement and caller merchandise motorboat execution.
BofA downgraded Reliance (RS) to Underperform from Neutral with a terms people of $365, up from $355. While near-term fundamentals stay supportive, equity upside is "now much valuation-constrained," the steadfast tells investors.